U.S. Markets open in 2 hrs 3 mins

Equillium to Present Translational Preclinical Data Demonstrating Increased Survival and Decreased Disease Severity in Models of Graft-Versus-Host Disease Treated with Itolizumab at the Transplantation & Cellular Therapy Meetings of ASTCT & CIBMTR

LA JOLLA, Calif., Jan. 29, 2020 (GLOBE NEWSWIRE) -- Equillium, Inc. (EQ), a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders, today announced that translational data supporting the potential of itolizumab in the treatment of graft-versus-host disease (GVHD) will be presented at the Transplantation & Cellular Therapy (TCT) Meetings of the American Society for Transplantation and Cellular Therapy (ASTCT) and the Center for International Blood & Marrow Transplant Research (CIBMTR) being held February 19-23, 2020 at the World Center Marriott in Orlando, Florida. The research, conducted in mouse models of human disease, demonstrates that blockade of the CD6-ALCAM pathway with anti-CD6 antibodies reduces incidence and severity of both GVHD and gastro-intestinal (GI) inflammation.

“Although GVHD is a leading cause of non-relapse mortality in patients following an allogeneic hematopoietic stem cell transplant, there are currently no approved therapies available for first-line treatment,” said Robert Soiffer, M.D., chief of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute. “This data further validates CD6 as an attractive target to selectively modulate T effector cell activity and as a potential therapeutic approach.”

Stephen Connelly, Ph.D., chief scientific officer of Equillium added, “We are encouraged by our research demonstrating that the blockade of the CD6-ALCAM pathway reduces the severity of GVHD and improves mortality rates associated with GVHD and GI inflammation in multiple humanized in vivo models, supporting its use as a potential therapy for severe inflammatory disorders driven by T effector cells. We continue to investigate the safety and clinical activity of itolizumab in patients with acute GVHD in the EQUATE trial, an ongoing Phase 1b/2 clinical trial.”

Below is the abstract title that has been selected for a poster presentation. Full text of the abstracts can be found on the conference website.  Once the TCT poster presentations are made public, they will be available in the Investors section of Equillium’s website.

Poster Presentation
Title: Targeting the CD6-ALCAM Pathway to Prevent and Treat Graft vs. Host Disease
First Author: Cherie Ng, Ph.D., MPH
Date and Time: February 19, 2020 from 6:30 - 8:00 p.m. ET
Session: Poster Session I: Graft-Versus-Host and Graft-Versus-Tumor - Basic/Pre-Clinical
Poster Number: 250

About Equillium
Equillium is a clinical-stage biotechnology company leveraging deep understanding of immunobiology to develop products to treat severe autoimmune and inflammatory disorders with high unmet medical need.

Equillium’s initial product candidate, itolizumab (EQ001), is a clinical-stage, first-in-class monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. CD6 plays a central role in modulating the activity and trafficking of T cells that drive a number of immuno-inflammatory diseases. Itolizumab is a clinically-validated therapeutic that has demonstrated a favorable safety and tolerability profile. Equillium acquired rights to itolizumab through an exclusive partnership with Biocon Limited. Equillium believes that itolizumab has the potential to be a best-in-class disease modifying therapeutic and is advancing the clinical development of itolizumab in the following severe immuno-inflammatory disorders: uncontrolled asthma, acute graft-versus-host disease, and lupus nephritis. For more information, visit www.equilliumbio.com.

Forward-Looking Statements
Statements contained in this press release regarding matters that are not historical facts are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Such statements include, but are not limited to, statements regarding Equillium’s plans for developing itolizumab for the treatment of GVHD and the potential benefits of itolizumab for GVHD. Risks that contribute to the uncertain nature of the forward-looking statements include uncertainties related to the impact of certain translational research, completion of clinical trials and whether the results from clinical trials will validate and support the safety and efficacy of itolizumab for GVHD. These and other risks and uncertainties are described more fully under the caption "Risk Factors" and elsewhere in Equillium's filings and reports with the United States Securities and Exchange Commission. All forward-looking statements contained in this press release speak only as of the date on which they were made. Equillium undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Investor Contact
+1-858-412-5302
ir@equilliumbio.com

Media Contact
Cammy Duong
Canale Communications
+1-619-849-5389
cammy@canalecomm.com

  • Elon Musk Calls Bill Gates Underwhelming After Billionaire Buys a Porsche
    Business
    Bloomberg

    Elon Musk Calls Bill Gates Underwhelming After Billionaire Buys a Porsche

    If he was expecting kind words in return from Elon Musk, he apparently shouldn't have spoken about challenges that still lie ahead -- or about his new Porsche. Gates, the billionaire co-founder of Microsoft Corp., spoke with a YouTube influencer last week about the challenges of reducing emissions to slow climate change. “And certainly Tesla, if you had to name one company that's helped drive that, it's them,” Gates told YouTuber Marques Brownlee.

  • What ‘Rothifying’ 401(k)s Would Mean for Retirees
    Business
    The Wall Street Journal

    What ‘Rothifying’ 401(k)s Would Mean for Retirees

    Research shows that switching 401(k)s to after-tax contributions would boost tax returns in the short term, but leave retirees worse off.

  • Shades of Detroit? Germany's auto heartlands in peril as 'golden age' fades
    Business
    Reuters

    Shades of Detroit? Germany's auto heartlands in peril as 'golden age' fades

    At the Schmitts' plant in Hallstadt, workers are trying to avoid forced layoffs; at a Bosch factory in nearby Bamberg, pay cuts and reduced hours have been agreed, as has investment in new fuel cell technology. With pockets of rising joblessness in the affluent, auto-producing heartlands of Bavaria and Baden-Wuerttemberg in southern Germany, there are serious implications for a country which relies on the car industry for roughly 5% of its economic output and, and an important part of its national identity. "Germany is entering uncharted waters.

  • Roku, Inc. Just Released Its Yearly Results And Analysts Are Updating Their Estimates
    Business
    Simply Wall St.

    Roku, Inc. Just Released Its Yearly Results And Analysts Are Updating Their Estimates

    Revenues came in at US$1.1b, in line with forecasts and the company reported a statutory loss of US$0.52 per share, roughly in line with expectations. Following the result, analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. So we gathered the latest post-earnings forecasts to see what analysts' statutory forecasts suggest is in store for next year.

  • Apple takes hit from coronavirus
    Business
    Reuters Videos

    Apple takes hit from coronavirus

    Apple became the biggest company to flag damage to its business from the coronavirus on Monday (February 17). It warned of an assault on two fronts: Supply is a problem with factories in China still slow to reopen and it sees sales of its devices falling off, too. Many of its stores in China are still closed or have limited hours.

  • Business
    Fox Business

    Want to become a Chick-fil-A operator? Here's how much it costs

    How much does it cost to open your own Chick-fil-A franchise? Proof that you're a self-starter with a good personal finance track record -- and $10,000. Chick-fil-A, the nation's top fast-food chain, relies on a franchise business model.

  • Meet the new IRS tax form specially designed for people 65 and older
    Business
    MarketWatch

    Meet the new IRS tax form specially designed for people 65 and older

    To say that the new Form 1040-SR closely mirrors the 2019 version of the “regular” Form 1040 is an understatement. * Instructions for both the new Form 1040-SR and the 2019 version of the regular Form 1040 are included in the same document (TAX YEAR 2019 1040 and 1040-SR INSTRUCTIONS). For both the new Form 1040-SR and the 2019 version of the regular Form 1040, IRA distributions and income from pensions and annuities are reported on separate lines on page 1 of the forms.

  • 2 “Strong Buy” Healthcare Stocks with Over 100% Upside Potential
    Business
    TipRanks

    2 “Strong Buy” Healthcare Stocks with Over 100% Upside Potential

    Naturally, the research should include what the pros on the Street think about a company's long-term growth narrative. Using TipRanks' Stock Screener, we've dug up two healthcare stocks that look especially promising. While each one is unique, the tickers have two things in common: all have room for upside of more than 100%, and what's more, each one currently boasts a “Strong Buy” consensus rating from the Street.

  • Germany's $93 Billion Train Project Looks Fantastic, for France
    Business
    Bloomberg

    Germany's $93 Billion Train Project Looks Fantastic, for France

    Five years later Alstom is involved in another transformational deal, only this time it's in the driving seat, while Canadian manufacturer Bombardier Inc. is the one in need of emergency balance sheet help, having burned through cash because of delayed aircraft projects and mismanaged rail contracts. On Monday the Canadian conglomerate completed a downsizing that's every bit as drastic as Alstom's was. The French manufacturer has agreed to pay about 6 billion euros ($6.5 billion) for Bombardier's rail activities, which account for about half of the Canadian company's sales.

  • Dow Jones Futures: Apple Warns On Coronavirus, Walmart Earnings Miss
    Business
    Investor's Business Daily

    Dow Jones Futures: Apple Warns On Coronavirus, Walmart Earnings Miss

    Dow Jones futures fell Tuesday morning, along with S&P 500 futures and Nasdaq futures, as Apple warned it won't meet revenue guidance as the China coronavirus hits iPhone production and demand. Fellow Dow Jones giant Walmart reported a surprise earnings decline. Last week, Tesla cited "health epidemics" as a risk and Alibaba warned that the coronavirus was a "black swan" event.

  • David Tepper's Top 5 Buys in the 4th Quarter
    Business
    GuruFocus.com

    David Tepper's Top 5 Buys in the 4th Quarter

    David Tepper (Trades, Portfolio), founder of Appaloosa Management, disclosed last week that his fund's top five buys during the fourth quarter of 2019 included a new holding in Intelsat SA (NYSE:I) and position boosts in four companies: Alibaba Group Holding Ltd. (NYSE:BABA), Micron Technology (NASDAQ:MU), Energy Transfer LP (NYSE:ET) and Amazon.com Inc. NASDAQ:AMZN). Warning!

  • Tesla Bear Morgan Stanley Raises Its Bull Case to $1,200 a Share
    Business
    Bloomberg

    Tesla Bear Morgan Stanley Raises Its Bull Case to $1,200 a Share

    Morgan Stanley's Adam Jonas increased his most optimistic projection for Tesla to $1,200 a share from $650. Jonas raised his base case target to $500 a share from $360 but reiterated his underweight recommendation. The new bull scenario is based on an “aggressive assumption” that Tesla could win 30% of the global electric-vehicle market, Jonas wrote in a report to clients.

  • Business
    Oilprice.com

    The World’s Top LNG Producer Is In Trouble

    Global LNG markets are struggling with a glut of unprecedented levels. International expansion in Australia, Qatar, Mozambique and Egypt, combined with a continuously strong US shale gas export drive, is pushing down prices further. Analysts have warned before that a possible LNG glut could end in tears, but nobody was expecting that the market would also be hit by a demand side shock such as China's coronavirus.

  • French finance minister warns Renault against job cuts, factory closures
    Business
    Reuters

    French finance minister warns Renault against job cuts, factory closures

    French Finance Minister Bruno Le Maire warned Renault on Tuesday against shutting factories in France and cutting jobs there after the carmaker announced "no taboos" cost cuts last week. Renault reported on Friday its first loss in a decade which triggered a commitment to cut costs by 2 billion euros ($2.2 billion) over the next three years, in a plan that could also hit plants in France, its interim chief said. "The state will play its role as shareholder in Renault to make sure that the choices which will be made will not go against jobs and factories in France," Le Maire told journalists in Brussels, adding the government would talk with the carmaker and remain "very vigilant" on its cost cuts strategy.

  • News
    Barrons.com

    The Secure Act Requires Your 401(k) Statement to Show Monthly Retirement Income. You Could Be in for a Surprise.

    Translating the nebulous balance on a 401(k) statement into an estimated monthly income in retirement can be challenging, leaving workers unsure whether they're on the right track or need to step up their contributions. A small provision in the Secure Act, signed into law in December to help Americans save for retirement, aims to remove some of that uncertainty. The law requires employers offering 401(k) plans and similar plans to show employees not just the total balance in their account but also a projected monthly income in retirement based on that balance.

  • Huawei Scare Pushes Carriers to Tackle Dominance of 5G Suppliers
    Business
    Bloomberg

    Huawei Scare Pushes Carriers to Tackle Dominance of 5G Suppliers

    Companies including Deutsche Telekom AG and Vodafone Group Plc have decided to combine separate projects to develop a more standardized, flexible network architecture that would make it easier for carriers to use products from multiple vendors, according to people familiar with the matter. Under the plans, the O-RAN industry alliance, backed by Deutsche Telekom and AT&T Inc. among others, will align its work with the Telecom Infra Project, which was started by Facebook Inc.

  • President Trump Attends Trump Hotel Wedding of White House Aides Stephen Miller and Katie Waldman
    Politics
    Meredith Videos

    President Trump Attends Trump Hotel Wedding of White House Aides Stephen Miller and Katie Waldman

    President Trump Attends Trump Hotel Wedding of White House Aides Stephen Miller and Katie Waldman

  • Kroger stock soars after Buffett’s investment
    Business
    American City Business Journals

    Kroger stock soars after Buffett’s investment

    Kroger Co.'s stock soared in after-hours trading Friday following the disclosure that famed investor Warren Buffett's Berkshire Hathaway conglomerate has made a huge investment in the supermarket giant's stock. Omaha, Neb.-based conglomerate Berkshire Hathaway bought a new position of 18.9 million shares of Kroger (NYSE: KR) stock during the fourth quarter, according to a Securities and Exchange Commission filing late Friday.

  • Exclusive: Tesla in talks to use CATL's cobalt-free batteries in China-made cars - sources
    Business
    Reuters

    Exclusive: Tesla in talks to use CATL's cobalt-free batteries in China-made cars - sources

    Tesla is in advanced stages of talks to use batteries from CATL that contain no cobalt - one of the most expensive metals in electric vehicle (EV) batteries - in cars made at its China plant, people familiar with the matter said. Adoption would mark the first time for the U.S. automaker to include so-called lithium iron phosphate (LFP) batteries in its lineup, as it seeks to lower production costs amid faltering overall EV sales in China. Tesla has been talking to the Chinese manufacturer for more than a year to supply LFP batteries that will be cheaper than its existing batteries by a "double-digit percent," said a person directly involved in the matter, who was not authorised to speak with media and so declined to be identified.

  • Business
    MarketWatch

    Medtronic's stock falls after profit beats but sales comes up shy

    Shares of Medtronic PLC (mdt) fell 1.4% in premarket trading Tuesday, after the Dublin-based medical technology company reported a fiscal third-quarter profit that beat expectations but revenue that missed. Net income rose to $1.92 billion, or $1.42 a share, from $1.27 billion, or 94 cents a share, in the year-ago period. Excluding non-recurring items, adjusted earnings per share came to $1.44, above the FactSet consensus of $1.38.

  • These 3 Chip Giants Keep Hitting New Highs: Are They Still Buys?
    Business
    TipRanks

    These 3 Chip Giants Keep Hitting New Highs: Are They Still Buys?

    To watch Steve's track record, click here) AMD's recent sharp gains have pushed the stock's share price well above the average price target, and analysts have not yet readjusted their outlook. As Steves' double target upgrade show, events in the chip industry are moving quickly. AMD's Moderate Buy consensus rating is based on mixed reviews, and includes 11 Buy and 13 Holds.

  • U.S. Futures Fall After Apple Warning; Bonds Gain: Markets Wrap
    Business
    Bloomberg

    U.S. Futures Fall After Apple Warning; Bonds Gain: Markets Wrap

    Treasuries rose and the dollar edged higher. Contracts on the three major U.S. equity benchmarks dropped, with Apple shares slumping as much as 4.2% in pre-market trading after the iPhone maker warned on both production and sales disruptions due to the epidemic. In Europe, tech companies were among the biggest laggards in the Stoxx 600 index as Apple suppliers including Dialog Semiconductor Plc and AMS AG slid.

  • Dow Jones Futures: Walmart Earnings Due, 3 IPOs Near Buys; Warren Buffett Stock Set To Break Out
    Business
    Investor's Business Daily

    Dow Jones Futures: Walmart Earnings Due, 3 IPOs Near Buys; Warren Buffett Stock Set To Break Out

    Dow Jones futures rose modestly Monday afternoon, along with S&P 500 futures and Nasdaq futures, after the stock market rally kept running last week. Walmart, Medtronic and InMode report earnings Tuesday. U.S. stock markets are closed for the Presidents Day holiday.

  • Business
    Barrons.com

    Tennessee’s Treasury Sold GE, GM, and Verizon Stock. Here’s What It Bought.

    The Tennessee Department of Treasury made some big changes in its stock investments in the last quarter of 2019. The department, which manages all of the state's investments, including its pension fund, reduced investments in (GE) (ticker: GE), General Motors (GM) and (VZ) Communications stock (VZ) in the fourth quarter. Tennessee's treasury also bought more (WMT) stock (WMT).

  • Strategists remain 'irrationally bullish' on the stock market: Morning Brief
    Business
    Yahoo Finance

    Strategists remain 'irrationally bullish' on the stock market: Morning Brief

    Subscribe Wall Street struggles to find a bear case for stocks The stock market has started 2020 a lot like it ended 2019: on a tear. Despite early-year worries over rising tensions in the Middle East and the recent outbreak of the coronavirus and still-unknown knock-on effects from the effective shutdown of China's economy, stocks last week powered to record highs. And this market action has led some Wall Street strategists to more or less conclude that right now, it is hard to build a credible bear case.